Author

O. Braissant

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:development & morphogenesis· 2 Organism:rat· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. Cudalbu· 2 shared C. Sandi· 2 shared G. Fernandes-Pires· 2 shared J. Grosse· 2 shared L. Duran-Trio· 2 shared P.-A. Binz· 2 shared A. F. Fesser· 1 shared C. Roux· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

C. Cudalbu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Creatine transporter deficient rat model show motor dysfunction, cerebellar alterations and muscle creatine deficiency without muscle atrophy

L. Duran-Trio, G. Fernandes-Pires, J. Grosse, I. Soro-Arnaiz, C. Roux-Petronelli, P.-A. Binz, K. De Bock, C. Cudalbu, C. Sandi, O. Braissant

bioRxiv · Oct 12, 2021Pathology

A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism

L. Duran-Trio, G. Fernandes-Pires, D. Simicic, J. Grosse, C. Roux, P.-A. Binz, C. Sandi, C. Cudalbu, O. Braissant

This study introduces a new rat model of creatine transporter deficiency, showing brain creatine deficiency, cognitive issues, and autistic features.

bioRxiv · Aug 11, 2020Pathology

Non-invasive monitoring of drug action: a new live in vitro assay design for Chagas' disease drug discovery

A. F. Fesser, O. Braissant, F. Olmo, J. M. Kelly, M. Kaiser, P. Maeser

This paper introduces a live in vitro assay using eGFP-expressing Trypanosoma cruzi to monitor drug action over 6 days, revealing pharmacodynamic profiles of benznidazole and posaconazole.

bioRxiv · Jan 15, 2020Microbiology